Boosting of Voriconazole Levels With Omeprazole, A CYP450 2C19 Inhibitor

Alice J. Hsu, Carlton K Lee, John Mcateer, Sean X. Zhang, Pranita D. Tamma

Research output: Contribution to journalArticlepeer-review

Abstract

Children metabolize voriconazole faster than adults and require higher weight-based doses and more frequent administration to achieve therapeutic troughs. We report a case of a 4-year-old girl with disseminated fusariosis with persistently undetectable voriconazole troughs. Omeprazole was added as a CYP2C19-inhibitor to increase voriconazole concentrations. This case highlights the role of omeprazole for voriconazole boosting in a child.

Original languageEnglish (US)
Pages (from-to)485-488
Number of pages4
JournalPediatric Infectious Disease Journal
Volume42
Issue number6
DOIs
StatePublished - Jun 1 2023

Keywords

  • CYP450 2C19 inhibitor
  • fusariosis
  • omeprazole
  • therapeutic drug monitoring
  • voriconazole

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Microbiology (medical)
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Boosting of Voriconazole Levels With Omeprazole, A CYP450 2C19 Inhibitor'. Together they form a unique fingerprint.

Cite this